XRX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Xerox (XRX)
NEW YORK CITY, NY / ACCESS Newswire / November 2, 2026 /Xerox Holdings Corporation (NASDAQ:XRX) shares sold off sharply on October 29, 2026, after the Company 's third-quarter report cut its full-year 2026 profit outlook while holding its revenue target at approximately $7.6 billion. If your XRX position lost value in the selloff, the investigation now underway may cover your losses. Shareholders who lost money on Xerox are encouraged to submit their loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Xerox maintained its full-year revenue guidance at approximately $7.6 billion but lowered its adjusted operating income outlook to $450 million-$475 million, down from $555 million-$605 million.
Management attributed the reduced outlook to an approximately $60 million headwind from higher memory and oil costs, a shift in product mix from mid-range to entry-level devices, a weaker print-market outlook, and lower-than-expected profit from its IT Solutions business. Levi & Korsinsky is investigating potential securities law violations on behalf of Xerox shareholders who suffered losses.
Investors still carrying losses from the October 29 Xerox drop can request a free review of their XRX losses or call (212) 363-7500.
ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the XRX Investigation
Q: How much did XRX stock drop? A: Shares fell sharply on October 29, 2026, after the Company disclosed a cut to its full-year 2026 adjusted operating income guidance to $450 million to $475 million and its free-cash-flow guidance to $50 million to $100 million. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Xerox made materially false or misleading statements regarding its full-year 2026 adjusted operating income and free cash flow outlook. On October 29, 2026, when the Company disclosed reduced full-year adjusted operating income guidance from $555-$605 million to $450-$475 million and its free cash flow guidance from approximately $250 million to $50-$100 million, the stock price declined sharply.
Q: Who is eligible to participate in the XRX investigation? A: Investors who purchased XRX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do XRX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my XRX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought XRX and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys ' fees and expenses subject to court approval.
Q: What if I live outside the United States? A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor 's country of residence.
Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE:Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
